Researchers race to develop Paxlovid replacement

Researchers from Rutgers believe themselves among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—the antiviral medication that helps keep high-risk patients out of the hospital and from dying.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart